These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17237395)

  • 1. Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration.
    Scandella E; Fink K; Junt T; Senn BM; Lattmann E; Förster R; Hengartner H; Ludewig B
    J Immunol; 2007 Feb; 178(3):1468-76. PubMed ID: 17237395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.
    Ciavarra RP; Greene AR; Horeth DR; Buhrer K; van Rooijen N; Tedeschi B
    Immunology; 2000 Dec; 101(4):512-20. PubMed ID: 11122455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs.
    Ludewig B; Maloy KJ; López-Macías C; Odermatt B; Hengartner H; Zinkernagel RM
    Eur J Immunol; 2000 Jan; 30(1):185-96. PubMed ID: 10602040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL.
    Junt T; Scandella E; Förster R; Krebs P; Krautwald S; Lipp M; Hengartner H; Ludewig B
    J Immunol; 2004 Dec; 173(11):6684-93. PubMed ID: 15557160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal.
    Fehr T; Bachmann MF; Bluethmann H; Kikutani H; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Mar; 168(2):184-92. PubMed ID: 8640864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
    Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
    Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of long-lived germinal centers associated with persisting antigen after viral infection.
    Bachmann MF; Odermatt B; Hengartner H; Zinkernagel RM
    J Exp Med; 1996 May; 183(5):2259-69. PubMed ID: 8642335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell activation state-governed formation of germinal centers following viral infection.
    Fink K; Manjarrez-Orduño N; Schildknecht A; Weber J; Senn BM; Zinkernagel RM; Hengartner H
    J Immunol; 2007 Nov; 179(9):5877-85. PubMed ID: 17947661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral B cell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/- mice.
    Karrer U; López-Macías C; Oxenius A; Odermatt B; Bachmann MF; Kalinke U; Bluethmann H; Hengartner H; Zinkernagel RM
    J Immunol; 2000 Jan; 164(2):768-78. PubMed ID: 10623822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
    Schmidt MR; Gravel KA; Woodland RT
    J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance?
    Ciavarra RP; Stephens A; Nagy S; Sekellick M; Steel C
    J Immunol; 2006 Jul; 177(1):492-500. PubMed ID: 16785546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules.
    Fehr T; López-Macías C; Odermatt B; Torres RM; Schubart DB; O'Keefe TL; Matthias P; Hengartner H; Zinkernagel RM
    Int Immunol; 2000 Sep; 12(9):1275-84. PubMed ID: 10967022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 Controls T Helper Cell Activation During Viral Infection.
    Goncalves-Alves E; Saferding V; Schliehe C; Benson R; Kurowska-Stolarska M; Brunner JS; Puchner A; Podesser BK; Smolen JS; Redlich K; Bonelli M; Brewer J; Bergthaler A; Steiner G; Blüml S
    Front Immunol; 2019; 10():1367. PubMed ID: 31275315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
    Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology. Memory T cells--local heroes in the struggle for immunity.
    Mackay CR; von Andrian UH
    Science; 2001 Mar; 291(5512):2323-4. PubMed ID: 11269302
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of lymphotoxin beta governs immunity at two distinct levels.
    Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
    Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses.
    Junt T; Fink K; Förster R; Senn B; Lipp M; Muramatsu M; Zinkernagel RM; Ludewig B; Hengartner H
    J Immunol; 2005 Dec; 175(11):7109-16. PubMed ID: 16301613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.
    Maloy KJ; Burkhart C; Junt TM; Odermatt B; Oxenius A; Piali L; Zinkernagel RM; Hengartner H
    J Exp Med; 2000 Jun; 191(12):2159-70. PubMed ID: 10859340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection.
    Maloy KJ; Burkhart C; Freer G; Rülicke T; Pircher H; Kono DH; Theofilopoulos AN; Ludewig B; Hoffmann-Rohrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Mar; 162(5):2867-74. PubMed ID: 10072535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.